Concert Health Completes $14 Million Series A Financing to Deliver Evidence-based Behavioral Health Services at Scale
Collaborative Care Management (CoCM) model gives providers and patients immediate access to high-quality behavioral health support in primary care
$14 million Series A led by Vertical Venture Partners
Partnerships with 44 medical groups and health systems including CommonSpirit provides access for millions of patients
Concert Health, a leading behavioral health medical group, announced the closing of its Series A funding round at $14 million led by Vertical Venture Partners with participation from Town Hall Ventures and Silicon Valley Bank, and continued support from early investors including Healthy Ventures and Clearvision Equity. The funds were a mix of equity and credit. The capital will be used to grow Concert’s clinical, technology and commercial teams to rapidly scale Concert’s exceptional, turnkey behavioral health services in primary care and women’s health settings.
Nearly half of Americans with behavioral health conditions receive no treatment. Even for patients that do get help, too often it only comes from an overtaxed primary care provider who lacks the support and expertise to intervene effectively and systematically track outcomes, with far-reaching consequences for both the patient and the health system. Clinically, over 80% of people identified with depression who do not receive measurement-based care still have symptoms a year later. Furthermore, studies show that uncontrolled behavioral health conditions such as depression or anxiety exacerbate other chronic conditions, worsening health and increasing health care expenditures by over 2.5 times in comparison to people without uncontrolled depression.
Recommended AI News: Cubic Announces FirstNet Ready Push-To-Talk Radio Gateway
Since 2018, Concert Health has been working to make high-quality behavioral health services available at the primary care level to Americans in need. The Collaborative Care Management (CoCM) model, which has been proven to significantly improve depression and anxiety outcomes compared with traditional primary care, is already a covered benefit nationally for Medicare, most commercial insurances, and Medicaid programs in 18 states. Concert’s team of expert Behavioral Care Managers and psychiatrists provides patients immediate access to evidence-based behavioral health support as part of their primary care team and supports providers in effectively diagnosing and treating these conditions to improve both physical and mental health. As a result, over 60% of Concert Health patients have seen their symptoms of depression or anxiety reduce by half within the first 90 days.
“The chasm between our physical and behavioral health systems leaves too many patients untreated, and leaves too many primary care physicians isolated,” said Spencer Hutchins, co-founder and CEO of Concert Health. “Concert Health’s mission is to re-architect America’s behavioral health system so that every patient has access to exceptional behavioral health services as part of their trusted primary care.”
Recommended AI News: Indeed Offers Hope to Job Seekers with Company’s First Super Bowl Spot
“Physicians need a way to quickly and effectively address patients’ behavioral health needs,” said Virna Little, LCSW, PsyD, co-founder and chief operating officer of Concert Health. “Primary care providers are treating a huge amount of depression alongside other chronic diseases without sufficient support. By providing same-day access to Concert Health’s expert clinicians we are making it easy for primary care providers to identify and treat patients with behavioral health conditions. Our behavioral care managers and psychiatrists serve as an extension of the existing care team, helping physicians treat patients’ overall health more effectively and ultimately delivering demonstrable outcomes for the health care system.”
“Concert Health has built a powerhouse clinical team coupled with a modern technology platform in an area of health that we all know needs effective models that scale,” said Dave Schwab, Founder and Managing Director at Vertical Venture Partners. “We are proud to support their growth, and look forward to collaborating with their management team to scale an industry-changing organization.”
Recommended AI News: RepRisk Provides ESG Risk Data to Yuanta Securities Investment Trust (Yuanta Funds)